Finance

Beta
Ask
Lists
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
$8.05
+2.16%
(+0.17) 1D
$8.50
+5.59% (+0.45)
Pre-market
Closed: Jun 17, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
$7.93
High
$8.46
Low
$7.93
Mkt. cap
149.15M
Avg. vol.
604.40K
Volume
666.00
52-wk high
$20.56
52-wk low
$6.73
EPS
-$5.81
Beta
2.57
Shares outstanding
18.53M
No. of employees
36
Open
$7.93
High
$8.46
Low
$7.93
Mkt. cap
149.15M
Avg. vol.
604.40K
Volume
666.00
52-wk high
$20.56
52-wk low
$6.73
EPS
-$5.81
Beta
2.57
Shares outstanding
18.53M
No. of employees
36
Analyst outlook
Analyst Ratings
Based on 10 analysts giving stock ratings to CRBP in the past 3 months
Strong Buy
Buy
10
Hold
0
Sell
0
12 month forecast
Based on 10 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current $8.05
$52.00 (+545.96%)
Average
$38.44 (+377.52%)
Lowest
$28.00 (+247.83%)
News stories
From sources across the web
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees36
FoundedJan 1, 2009
Headquarters-
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
15.19M
20.86M
18.41M
19.82M
Cost of revenue
15.19M
20.86M
18.41M
19.82M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.96M
3.56M
3.56M
4.48M
Operating expense
3.96M
3.56M
3.56M
4.48M
Total operating expenses
19.15M
24.42M
21.97M
24.30M
Operating income
-19.15M
-24.42M
-21.97M
-24.30M
Other non operating income
176.00K
-50.00K
-1.10M
-67.00K
EBT including unusual items
-17.66M
-23.34M
-20.56M
-22.97M
EBT excluding unusual items
-17.66M
-23.34M
-21.66M
-22.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.66M
-23.34M
-20.56M
-22.97M
Net profit margin
-
-
-
-
Earnings per share
-1.44
-1.90
-1.25
-1.23
Interest and investment income
1.31M
1.12M
1.41M
1.40M
Interest expense
-
-
-
-
Net interest expenses
1.31M
1.12M
1.41M
1.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.10M
-24.37M
-21.92M
-24.26M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more